Effectiveness of 7-valent pneumococcal conjugate vaccine against radiologically diagnosed pneumonia in indigenous infants in Australia

Bulletin of the World Health Organization

Volumn 88, Issue 2, 2010, Pages 139-146

  O'Grady, K F ^a   Carlin, J B ^b   Chang, A B ^c   Torzillo, P J ^d   Nolan, T M ^e   Ruben, A ^f   Andrews, R M ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

CHILD; COHORT ANALYSIS; DISEASE INCIDENCE; PATHOTYPE; PNEUMONIA; VACCINE; WORLD HEALTH ORGANIZATION;

ARTICLE; AUSTRALIA; CHILD; COHORT ANALYSIS; DRUG EFFICACY; ETHNIC GROUP; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; PATHOGENESIS; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; VACCINATION; WORLD HEALTH ORGANIZATION;

AGE FACTORS; AUSTRALIA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; OCEANIC ANCESTRY GROUP; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; TIME FACTORS; VACCINES, CONJUGATE;

STREPTOCOCCUS PNEUMONIAE;

EID: 75649125636     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.09.068239     Document Type: Article

References (31)

1. Carville KS, Lehmann D, Hall G, Moore H, Richmond P, de Klerk N, et al. Infection is the major component of the disease burden in Aboriginal and non-Aboriginal Australian children: a population-based study. Pediatr Infect Dis J 2007;26:210-6. PMID:17484216
2. Hanna J, Torzillo P. Acute respiratory infections in Australian Aboriginal children: current knowledge and future requirements. P N G Med J 1991;34:204-10. PMID:1750265
3. O'Grady K, Taylor-Thomson D, Chang A, Torzillo P, Morris P, Mackenzie G, et al. High rates of World Health Organization-defined radiologically confirmed pneumonia in Australian Indigenous children. Med J Aust 2009. In press.
4. Torzillo PJ, Gratten M. Conjugate pneumococcal vaccines for Aboriginal children in Australia. Med J Aust 2000;173 Suppl;S51. PMID:11062809
5. Torzillo P, Dixon J, Manning K, Hutton S, Gratten M, Hueston L, et al. Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children. Pediatr Infect Dis J 1999;18:714-21. doi:10.1097/00006454- 199908000-00012 PMID:10462342
6. Krause VL, Reid SJ, Merianos A. Invasive pneumococcal disease in the Northern Territory of Australia, 1994-1998. Med J Aust 2000;173 Suppl;S27. PMID:11062803
7. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187. doi:10.1097/00006454-200003000- 00003 PMID:10749457
8. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. Geneva: World Health Organization; 2001.
9. Clucas DB, Carville K, Connors C, Currie BJ, Carapetis JR, Andrews RM. Disease burden and health-care clinic attendances for young children in remote Aboriginal communities of northern Australia. Bull World Health Organ 2008;86:275-81. doi:10.2471/BLT.07.043034 PMID:18438516
10. Kleinbaum DG, Klein M. Survival analysis: a self-learning text. 2nd edn. New York, NY: Springer; 2005.
11. Clayton D, Hills M. Statistical models in epidemiology. Oxford: Oxford University Press; 2005.
12. Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002;21:810. doi:10.1097/00006454-200209000-00005 PMID:12352800
13. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005;365:1139-46. doi:10.1016/S0140- 6736(05)71876-6 PMID:15794968
14. Klugman KP, Madhi SA, Heubner R, Kohberger R, Mbelle N, Pierce NF, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8. doi:10.1056/ NEJMoa035060 PMID:14523142
15. Lucero MG, Nohynek H, Williams G, Tallo V, Simoes EA, Lupisan S, et al. Efficacy of an 11-Valent PneumococcalConjugate Vaccine Against Radiologically Confirmed Pneumonia Among Children Less Than 2 Years of Age in the Philippines: A Randomized, Double-Blind, Placebo-Controlled Trial. Pediatr Infect Dis J 2009;28:455-62. doi:10.1097/INF.0b013e31819637af PMID:19483514
16. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007;369:1179-86. doi:10.1016/S0140-6736(07)60564-9 PMID:17416262
17. Nelson JC, Jackson M, Yu O, Whitney CG, Bounds L, Bittner R, et al. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 2008;26:4947-54. doi:10.1016/j.vaccine.2008.07.016 PMID:18662735
18. Leach A, Mackenzie G, Mellon G, Wilson C, Hare K, Smith-Vaughan HC, et al. Emerging serotypes following universal pneumococcal conjugate vaccine (7vPCV). Paper presented at: Communicable Disease Control Conference 2007, Canberra, Australia, 4-15 March 2007.
19. Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Commun Dis Intell 2008;32 Suppl;S2-67. PMID:18711998
20. Moore H, Burgner D, Carville K, Jacoby P, Richmond P, Lehmann D. Diverging trends for lower respiratory infections in non-Aboriginal and Aboriginal children. J Paediatr Child Health 2007;43:451-7. doi:10.1111/j.1440- 1754.2007.01110.x PMID:17535175
21. Smith-Vaughan HC, Leach AJ, Shelby-James TM, Kemp K, Kemp DJ, Mathews JD. Carriage of multiple ribotypes of non-encapsulated Haemophilus influenzae in Aboriginal infants with otitis media. Epidemiol Infect 1996;116:177-83. doi:10.1017/S0950268800052419 PMID:8620909
22. Klugman KP, Madhi SA, Albrich WC. Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin Infect Dis 2008;47 Suppl 3;S202-6. doi:10.1086/591405 PMID:18986290
23. Madhi SA, Heera JR, Kuwanda L, Klugman KP. Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumonia. PLoS Med 2005;2:e38. doi:10.1371/journal.pmed.0020038 PMID:15736995
24. Madhi SA, Kohler M, Kuwanda L, Cutland C, Klugman KP. Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatr Infect Dis J 2006;25:30-6. doi:10.1097/01.inf.0000195787.99199.4a PMID:16395099
25. Cheung YB, Zaman SM, Ruopuro ML, Enwere G, Adegbola RA, Greenwood B, et al. C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children. Trop Med Int Health 2008;13:603-11. PMID:18331385
26. Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J 1994; 13:983-9. PMID:7845752
27. Leach AJ. Otitis media in Australian Aboriginal children: an overview. Int J Pediatr Otorhinolaryngol 1999;49 Suppl 1;S173-8. doi:10.1016/S0165- 5876(99)00156-1 PMID:10577800
28. O'Grady KA, Krause V, Andrews R. Immunisation coverage in Australian Indigenous children: Time to move the goal posts. Vaccine 2009;27:307-12. PMID:18977263
29. Szklo M, Javier Nieto F. Epidemiology: beyond the basics. Gaithersburg, MD: Aspen Publishers; 2000.
30. Mulholland K. Global burden of acute respiratory infections in children: implications for interventions. Pediatr Pulmonol 2003;36:469-74. doi:10.1002/ppul.10344 PMID:14618637
31. O'Grady KF, Lee KJ, Carlin JB, Torzillo PJ, Chang AB, Mulholland EK, et al. Increased risk of hospitalised acute lower respiratory infections in Australian Indigenous infants aged 5-23 months following pneumococcal vaccination: a cohort study. Clin Infect Dis 2009. In press.